Developing fast-acting antimalarial drugs that target sodium balance in malaria parasites
Advancing Fast-acting Antimalarials that Disrupt Na+ Homeostasis in Parasites
This study is looking for new malaria medicines that can help clear the parasite from your blood faster than the treatments we have now, making it easier for people with malaria to feel better quickly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10894723 on NIH RePORTER |
What this research studies
This research focuses on creating new antimalarial medications that effectively disrupt sodium homeostasis in the malaria-causing parasite, Plasmodium falciparum. The approach involves testing various compounds that have shown promise in early clinical trials for their ability to clear parasites from the bloodstream more rapidly than current treatments. By targeting a specific enzyme in the parasite, the research aims to develop drugs that can overcome the challenge of drug resistance and provide faster relief for patients suffering from malaria. The study will involve laboratory experiments and clinical trials to evaluate the efficacy and safety of these new compounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with malaria, particularly those infected with Plasmodium falciparum or Plasmodium vivax.
Not a fit: Patients who do not have malaria or are not infected with the specific strains targeted by this research may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antimalarial drugs that work faster and are more effective against resistant strains of malaria.
How similar studies have performed: Previous research has shown success with similar approaches targeting sodium homeostasis in malaria parasites, indicating a promising avenue for new treatments.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vaidya, Akhil B — Drexel University
- Study coordinator: Vaidya, Akhil B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.